PRE-CLINICAL ACTIVITY OF THE PI3K INHIBITOR BKM120 ON ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Allegretti, M. [1 ]
Ricciardi, M. R. [1 ]
Licchetta, R. [1 ]
Mirabilii, S. [1 ]
Amadori, S. [2 ]
Foa, R. [1 ]
Tafuri, A. [1 ]
机构：
[1] Univ Roma La Sapienza, I-00185 Rome, Italy
[2] Tor Vergata Univ Hosp, Rome, Italy
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P798
引用
收藏
页码：291 / 291
页数：1
相关论文
共 50 条
  • [11] Phase II trial of the phosphatidyinositol-3 kinase (PI3K) inhibitor BKM120 in recurrent glioblastoma (GBM)
    Wen, Patrick Y.
    Yung, W. K. Alfred
    Mellinghoff, Ingo K.
    Lamborn, Kathleen
    Ramkissoon, Shakti
    Cloughesy, Timothy Francis
    Rinne, Mikael
    Omuro, Antonio Marcilio Padula
    DeAngelis, Lisa Marie
    Gilbert, Mark R.
    Chi, Andrew S.
    Batchelor, Tracy
    Colman, Howard
    Chang, Susan Marina
    Massacesi, Cristian
    DiTomaso, Emmanuelle
    Prados, Michael
    Reardon, David A.
    Ligon, Keith L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [12] The PI3K Specific Inhibitor BKM120 Results Effective and Synergizes With Ruxolitinib In Preclinical Models Of Myeloproliferative Neoplasms
    Bartalucci, Niccolo
    Bogani, Costanza
    Martinelli, Serena
    Mannarelli, Garmela
    Villeval, Jean-Luc
    Vannucchi, Alessandro M.
    BLOOD, 2013, 122 (21)
  • [13] The PI3K/mTOR Inhibitor NVP-BEZ235 Is a Promising Pre-Clinical Candidate for Therapeutic Intervention in Acute Myeloid Leukemia.
    Chapuis, Nicolas
    Tamburini, Jerome
    Macone, Alexandre
    Green, Alexa Samantha
    Bardet, Valerie
    Willems, Lise
    Park, Sophie
    Ifrah, Norbert
    Dreyfus, Francois
    Maira, Sauveur-Michel
    Mayeux, Patrick
    Lacombe, Catherine
    Bouscary, Didier
    BLOOD, 2009, 114 (22) : 423 - 424
  • [14] Effective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancer
    Wang, Dong
    Wang, Min
    Jiang, Nan
    Zhang, Yuan
    Bian, Xing
    Wang, Xiaoqing
    Roberts, Thomas M.
    Zhao, Jean J.
    Liu, Pixu
    Cheng, Hailing
    ONCOTARGET, 2016, 7 (11) : 13153 - 13166
  • [15] Synergistic effects of BKM120 and panobinostat on pre-B acute lymphoblastic cells: an emerging perspective for the simultaneous inhibition of PI3K and HDACs
    Mehrpouri, Mahdieh
    Momeny, Majid
    Bashash, Davood
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2022, 42 (01) : 100 - 108
  • [16] The effect combining the KIT inhibitor Imatinib with the PI3K inhibitor BKM120 or the dual PI3K/mTOR inhibitor BEZ235 on the proliferation of gastrointestinal stromal tumor cell lines
    Li, Fang
    Growney, Joseph
    Battalagine, Linda
    Qiu, Shumei
    Manley, Paul
    Monahan, John
    CANCER RESEARCH, 2012, 72
  • [17] The Phosphatidylinositol-3-Kinase Inhibitor BKM120 Impairs Proliferation and Induces Pro-Apoptotic Effects In Acute Myeloid Leukemia
    Allegretti, Matteo
    Ricciardi, Maria Rosaria
    Vincenzi, Martina
    Licchetta, Roberto
    Mirabilii, Simone
    Amadori, Sergio
    Foa, Robin
    Tafuri, Agostino
    BLOOD, 2013, 122 (21)
  • [18] Apoptin Overexpression Efficiently Amplified Cytotoxic Effects of PI3K Inhibition Using BKM120 in Lymphoblastic Leukemia Cell Lines
    Anjam-Najmedini, Ali
    Vahabpour, Rohollah
    Safaroghli-Azar, Ava
    Kazemi, Alireza
    Movahhed, Parvaneh
    Momeny, Majid
    Bashash, Davood
    ADVANCED PHARMACEUTICAL BULLETIN, 2022, 12 (03) : 613 - 622
  • [19] PI3K inhibition by BKM120 results in anti-proliferative effects on corticotroph tumor cells
    H. A. Oliveira
    A. C. Bueno
    R. S. Pugliesi
    R. M. P. da Silva Júnior
    M. de Castro
    C. S. Martins
    Journal of Endocrinological Investigation, 2022, 45 : 999 - 1009
  • [20] PI3K inhibition by BKM120 results in anti-proliferative effects on corticotroph tumor cells
    Oliveira, H. A.
    Bueno, A. C.
    Pugliesi, R. S.
    da Silva Junior, R. M. P.
    de Castro, M.
    Martins, C. S.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (05) : 999 - 1009
12345